PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer

NCT02910882 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Safety

Conditions

Pancreatic Adenocarcinoma Non-resectable

Interventions

DRUG: PEGylated Recombinant Human Hyaluronidase (PEGPH20)
DRUG: Gemcitabine
RADIATION: Radiation

Sponsor

Scripps Health